P2X7 polymorphism and chronic lymphocytic leukaemia: Lack of correlation with incidence, survival and abnormalities of chromosome 12

Leukemia

Volumn 17, Issue 11, 2003, Pages 2097-2100

  Zhang, L Y ^a,b   Ibbotson, R E ^c   Orchard, J A ^c   Gardiner, A C ^c   Seear, R V ^a   Chase, A J ^a   Oscier, D G ^c   Cross, N C P ^a  

^a WESSEX REGIONAL GENETICS LABORATORY   (United Kingdom)

^b SHANDONG UNIVERSITY   (China)

^c ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

CLL; P2X7; Trisomy 12

Indexed keywords

ADENINE; ADENOSINE TRIPHOSPHATE; CYTOSINE; DNA; IMMUNOGLOBULIN HEAVY CHAIN; MEMBRANE RECEPTOR;

ADOLESCENT; ADULT; AGED; ALLELE; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CARCINOGENESIS; CHANNEL GATING; CHILD; CHROMOSOME 12; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE FREQUENCY; GENE LOCATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN FUNCTION; SEQUENCE ANALYSIS; TRISOMY 12;

EID: 0242475252     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403125     Document Type: Article

References (16)

1. Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med 1995; 333: 1052-1057.
2. Hamblin T. Chronic lymphocytic leukaemia: one disease or two? Ann Hematol 2002; 81: 299-303.
3. Wiley JS, Gargett CE, Zhang W, Snook MB, Jamieson GP. Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel. Am J Physiol 1998; 275: C1224-1231.
4. Rassendren F, Buell GN, Virginio C, Collo G, North RA, Surprenant A. The permeabilizing ATP receptor, P2X7: cloning and expression of a human cDNA. J Biol Chem 1997; 272: 5482-5486.
5. Gu BJ, Zhang WY, Worthington RA, Sluyter R, Dao-Ung P, Petrou S et al. A Glu-496 to Ala polymorphism leads to loss of function of human the P2X7 receptor. J Biol Chem 2001; 276: 11135-11142.
6. Wiley JS, Dao-Ung LP, Gu BJ, Sluyter R, Shemon AN, Li CP et al. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 2002; 359: 1114-1119.
7. Thunberg U, Tobin G, Johnson A, Soderberg O, Padyukov L, Hultdin M et al. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet 2002; 360: 1935-1939.
8. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated IgV(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848-1854.
9. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840-1847.
10. Oscier DC, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibboston RE et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100: 1177-1184.
11. Adinolfi E, Melchiorri L, Falzoni S, Chiozzip P, Morelli A, Tieghi A et al. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 2002; 99: 706-708.
12. Brito-Babapulle V, Garcia-Marco J, Maljaie SH, Hiorns L, Coignet L, Conchon M et al. The impact of molecular cytogenetics on chronic lymphoid leukaemia. Acta Haematol 1997; 98: 175-186.
13. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990-4997.
14. Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001; 29: E88-8.
15. Mattocks C, Tarpey P, Bobrow M, Whittaker J. Comparative sequence analysis (CSA): a new sequence-based method for the identification and characterization of mutations in DNA. Hum Mutat 2000; 16: 437-443.
16. Thunberg U, Tobin G, Johnson A, Enblad G, Rosenquist R. P2X7 polymorphism and chronic lymphocytic leukemia (letter). Lancet 2003; 361: 1478-1479.